SEC Tracker
Get the app

Onconetix ONCO

Onconetix advances $500K to Realbotix

Additional proxy materials

Form
DEFA14A
Filed
Importance
Routine
  1. $500,000 advance made on Oct 22, 2026
  2. Total principal under note now $3.0 million
  3. Note allows up to $5.0 million in loans

Written from the DEFA14A on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Onconetix files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Enveric Biosciences ENVB public float $4M, Jun 30, 2025
  2. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  3. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  4. Integrated Biopharma INBP public float $3M, Dec 31, 2025
  5. Jaguar Health JAGX public float $4M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.